| Literature DB >> 24314678 |
Christina Hughes1, Ileana M Howard.
Abstract
Spasticity is a prevalent and potentially disabling symptom common in individuals with multiple sclerosis. Adequate evaluation and management of spasticity requires a careful assessment of the patient's history to determine functional impact of spasticity and potential exacerbating factors, and physical examination to determine the extent of the condition and culpable muscles. A host of options for spasticity management are available: therapeutic exercise, physical modalities, complementary/alternative medicine interventions, oral medications, chemodenervation, and implantation of an intrathecal baclofen pump. Choice of treatment hinges on a combination of the extent of symptoms, patient preference, and availability of services.Entities:
Keywords: Antispasticity; Chemodenervation; Intrathecal baclofen; Multiple sclerosis; Spasticity
Mesh:
Substances:
Year: 2013 PMID: 24314678 DOI: 10.1016/j.pmr.2013.07.003
Source DB: PubMed Journal: Phys Med Rehabil Clin N Am ISSN: 1047-9651 Impact factor: 1.784